Seeking Alpha

Seeking Alpha Portfolio App for iPad

Theodore Cohen

Theodore Cohen picture

Profile

Send Message

View as an RSS Feed

View Theodore Cohen's Articles BY TICKER:

Dendreon: New Trial Sequencing Provenge With Xtandi To Begin Q4
on Thu, May 9 • MDVN, DNDN • 32 Comments
ViroPharma's Maribavir: Rising Like Phoenix
on Wed, May 1 • VPHM • 2 Comments
Dendreon's Provenge Ads: Are They Working?
on Wed, Apr 3 • JNJ, MDVN, DNDN • 27 Comments
Amgen's And Vical's Melanoma Trials: Questions
on Wed, Mar 27 • ONCS.OB, AMGN, VICL • 38 Comments
Dynavax Surprises: Announces Strategic Global Operations Hire
on Fri, Mar 22 • NVS, DVAX • 11 Comments
Dendreon Jump-Starts Its New Direct-To-Consumer Ad Campaign
on Fri, Mar 8 • DNDN • 45 Comments
The Dendreon Bear Raid Of 2009: Chasing The Perpetrators
on Mon, Mar 4 • POZN, DNDN • 44 Comments
Dynavax: A Takeover Target?
on Wed, Feb 27 • AZN, BMY, GSK • 22 Comments
Dynavax: The Path Forward
on Tue, Feb 26 • DVAX • 31 Comments
Dendreon: Startling Results Sequencing Provenge After Medivation's Xtandi
on Mon, Feb 25 • JNJ, MDVN, DNDN • 29 Comments
2013 GU: Dendreon's Neuvenge, A First Look At The Clinical Trial Results
on Fri, Feb 15 • DNDN • 14 Comments
2013 GU: Dendreon's Provenge Can Be Co-Administered With Johnson & Johnson's Zytiga
on Wed, Feb 13 • JNJ, DNDN • 24 Comments
Vical's Herpes Vaccine: New Lab Results Confirm Move To The Clinic
on Mon, Feb 4 • VICL • 19 Comments
Dendreon's Provenge: Update With The President Of The Large Urology Group Practice Association
on Mon, Jan 28 • DNDN • 15 Comments
Dendreon's Provenge: New Opinion On Sequencing Agents Released
on Mon, Jan 7 • JNJ, MDVN, DNDN • 47 Comments
Dynavax Initiates New Phase I Trial For Lymphomas
on Tue, Dec 18, 2012 • DVAX • 8 Comments
Dendreon Dodges A Bullet
on Tue, Dec 11, 2012 • JNJ, DNDN • 32 Comments
Dendreon: New Provenge Trial Involves Drugs Shown To Shrink Tumors
on Mon, Dec 10, 2012 • DNDN • 20 Comments
Dynavax Crashes On Unexpected Panel Vote
on Fri, Nov 16, 2012 • DVAX • 40 Comments
Dynavax Shares Jump On Release Of FDA Briefing Materials
on Tue, Nov 13, 2012 • GSK, DVAX • 34 Comments
Vical's Allovectin: Update On The Phase III Trial
on Thu, Nov 8, 2012 • BMY, JNJ, VICL • 53 Comments
Dendreon: What's The Company Worth Per Share?
on Fri, Nov 2, 2012 • JNJ, DNDN • 64 Comments
Dynavax Advances Agonist For Asthma Into The Clinic
on Wed, Oct 31, 2012 • AZN, DVAX • 4 Comments
Will Dendreon Surprise The Street On October 30?
on Mon, Oct 22, 2012 • DNDN • 86 Comments
Dendreon's Provenge: Under Attack Once Again
on Mon, Oct 15, 2012 • DNDN • 78 Comments
Dendreon's Provenge: More Evidence Of A Greater Life Extension Survival Benefit
on Tue, Oct 2, 2012 • JNJ, DNDN • 40 Comments
Vical: Bulls Vs. Bears
on Thu, Sep 27, 2012 • VICL • 14 Comments
Vical... Roaring To Life
on Sun, Sep 23, 2012 • MDVN, REGN, VRTX • 28 Comments
Vical's Vaxfectin Comes Alive
on Thu, Sep 13, 2012 • BMY, VICL • 14 Comments
Dendreon's Provenge: Early Stage Use
on Mon, Aug 20, 2012 • JNJ, DNDN • 47 Comments
Dendreon: Who's That Knocking On Their Door?
on Sun, Jul 29, 2012 • ALPMF.PK, BIIB, BMY • 48 Comments
Interview With Vijay B. Samant, President And CEO, Vical Incorporated
on Tue, Jul 24, 2012 • JNJ, DNDN, VICL • 29 Comments